Lijin Feng
- Oncology top 10%
- Cancer-related Molecular Pathways 3
- Cancer Risks and Factors 1
-
- Cancer Genomics and Diagnostics 2
-
- Immune Cell Function and Interaction 2
-
- Gastric Cancer Management and Outcomes 2
- Renal cell carcinoma treatment 1
-
- Inflammatory Bowel Disease 2
- Glioma Diagnosis and Treatment 1
- Co-authors
- Yang XuHiroaki UranishiWei GuTongxiang LinXi ZhangMonica HollsteinWei ZhangS Oehen
- Partner nations
- ChinaUnited StatesNepal
In The Last Decade
Lijin Feng
23 papers receiving 770 citations
Peers
Comparison fields: 5 of 79
- Oncology 313
- Cancer Research 128
- Molecular Biology 424
- Immunology 123
- Internal Medicine 21
Countries citing papers authored by Lijin Feng
This map shows the geographic impact of Lijin Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lijin Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lijin Feng more than expected).
Fields of papers citing papers by Lijin Feng
This network shows the impact of papers produced by Lijin Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lijin Feng. The network helps show where Lijin Feng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lijin Feng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 2 | |
| 2 | 2022 | 1 | |
| 3 | 2021 | 12 | |
| 4 | 2021 | 18 | |
| 5 | 2020 | 12 | |
| 6 | 2020 | 2 | |
| 7 | 2020 | 2 | |
| 8 | 2020 | 22 | |
| 9 | 2019 | 119 | |
| 10 | 2019 | 28 | |
| 11 | 2017 | 29 | |
| 12 | 2016 | 18 | |
| 13 | 2015 | 7 | |
| 14 | 2015 | 6 | |
| 15 | 2014 | 88 | |
| 16 | 2014 | 24 | |
| 17 | 2012 | 5 | |
| 18 | 2006 | 89 | |
| 19 | 2005 | 193 | |
| 20 | 1996 | 59 |
About Lijin Feng
Lijin Feng is a scholar working on Oncology, Internal Medicine and Cancer Research, having authored 23 papers that have together received 778 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (3 papers), Cancer Genomics and Diagnostics (2 papers), Gastric Cancer Management and Outcomes (2 papers), Immune Cell Function and Interaction (2 papers), Inflammatory Bowel Disease (2 papers), Renal cell carcinoma treatment (1 paper), Cancer Risks and Factors (1 paper) and Glioma Diagnosis and Treatment (1 paper). The work is most often cited by research in Oncology (313 citations), Cancer Research (128 citations) and Molecular Biology (424 citations). Lijin Feng has collaborated with scholars based in China, United States and Nepal. Frequent co-authors include Yang Xu, Hiroaki Uranishi, Wei Gu, Tongxiang Lin, Xi Zhang, Monica Hollstein, Wei Zhang, S Oehen, Charles D. Surh and Ying Xia. Their work appears in journals such as The Journal of Experimental Medicine, Gastroenterology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.